EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Hydrogel-Based Immunomodulation of Tumor Immune Microenvironment in Hepatocellular Carcinoma: Current Strategies and Future Directions

Shanyong Zhang, Lei Ding, Tingting Hou, Dengjian Lin, Yuan Qu

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s576091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Shanyong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, The Second Hospital of Jilin University, Changchun, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor Microenvironment, Hydrogels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains one of the most aggressive malignancies, with poor prognosis and limited treatment options, particularly due to the immunosuppressive tumor immune microenvironment (TIME). Hydrogels have emerged as a promising biomaterial platform for local and controlled delivery of immunomodulatory agents, offering a novel strategy to remodel the TIME and enhance the efficacy of existing therapies. This review explores hydrogel-based strategies for immunomodulation in HCC, focusing on their potential to localize immune regulation, improve immune cell infiltration, and overcome immune evasion. Hydrogels can be engineered to encapsulate a range of therapeutic agents, including immune checkpoint inhibitors, cytokines, tumor antigens, and adjuvants, allowing for sustained release and targeted action within the tumor. The integration of hydrogels with therapies such as ablation, CAR-T cell therapy, and tumor vaccines has demonstrated synergistic effects, significantly enhancing antitumor immunity and reducing tumor recurrence. However, challenges remain in optimizing hydrogel composition, biocompatibility, degradation rates, and the efficiency of agent delivery. Personalized hydrogel-based therapies, tailored to individual patient's TIME, hold great potential for precision immunotherapy in HCC. This review highlights the current advances, challenges, and future directions for hydrogel-based immunomodulation strategies in HCC treatment, underscoring their transformative potential in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTumor MicroenvironmentHydrogelsHumansAnimalsImmunotherapyImmunomodulation

Stichwörter der Autor:innen

CAR-Tablationhepatocellular carcinomahydrogelsimmunotherapyprecision medicinetumor immune microenvironment

Substanzen

Hydrogels

Autor:innen und Institutionen

  • Department of Spine Surgery, The Second Hospital of Jilin University, Changchun, People's Republic of China.
  • Department of Orthopedics, The Second Hospital of Jilin University, Changchun, People's Republic of China.

Zitieren

APA

Zhang, S., Ding, L., Hou, T., Lin, D., & Qu, Y. (2026). Hydrogel-Based Immunomodulation of Tumor Immune Microenvironment in Hepatocellular Carcinoma: Current Strategies and Future Directions. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s576091

Vancouver

Zhang S, Ding L, Hou T, Lin D, Qu Y. Hydrogel-Based Immunomodulation of Tumor Immune Microenvironment in Hepatocellular Carcinoma: Current Strategies and Future Directions. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s576091

BibTeX
@article{Zhang2026,
  author = {Zhang, Shanyong and Ding, Lei and Hou, Tingting and Lin, Dengjian and Qu, Yuan},
  title = {Hydrogel-Based Immunomodulation of Tumor Immune Microenvironment in Hepatocellular Carcinoma: Current Strategies and Future Directions},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s576091}
}
Kostenlos starten →